Martin Griesshammer

Martin Griesshammer

Minden, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications

Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

Primary Myelofibrosis (PMF)-The German ONKOPEDIA Guideline 2025.

Journal: International journal of cancer
Published: February 07, 2026

The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).

The German ONKOPEDIA Guideline for Myelofibrosis in 2025-Recommendations of an MPN Expert Panel of the German Society for Hematology and Oncology (DGHO).

Journal: International journal of cancer
Published: February 07, 2026

Myelofibrosis: watch and wait or treat?

Myelofibrosis: watch and wait or treat?

Journal: Innere Medizin (Heidelberg, Germany)
Published: November 02, 2025

Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).

Prospective, non-interventional study of ruxolitinib therapy in patients with polycythaemia vera - German real-world data (PaVe study).

Journal: Annals of hematology
Published: October 22, 2025

Response to the commentary by Xu et al. on the PV-AIM study.

Response to the commentary by Xu et al. on the PV-AIM study.

Journal: Leukemia
Published: September 28, 2025

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity Therapy.

Journal: Cancers
Published: August 14, 2025

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus.

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus.

Journal: Dermatology and therapy
Published: August 11, 2025

Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).

Prediction of resistance to hydroxyurea therapy in patients with polycythemia vera: a machine learning study (PV-AIM) validated in a prospective interventional phase IV trial (HU-F-AIM).

Journal: Leukemia
Published: March 07, 2025

How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.

How I diagnose and treat patients in the pre-fibrotic phase of primary myelofibrosis (pre-PMF) - practical approaches of a German expert panel discussion in 2024.

Journal: Annals of hematology
Published: December 04, 2024

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

Journal: Pediatric blood & cancer
Published: October 10, 2024

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Journal: Leukemia
Published: August 13, 2024

Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.).

Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.).

Journal: Hamostaseologie
Published: July 15, 2024
Showing 1-12 of 102

Last Updated: 09/26/2026